MAPT and cancer: A cross-sectional, proof-of-concept pilot study performed tau positron emission tomography imaging with flortaucipir (18F) on patients with dementia or mild cognitive impairment after cancer treatment and showed that chemotherapy patients with episodic memory impairment had paired helical filament tau deposition in an AD-like pattern.152